Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23319,99,1.20 [0.92-1.57],0.1727596576422514
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23950,181,1.09 [0.89-1.32],0.4117800953470379
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23718,1159,1.12 [1.04-1.21],0.0034420426149018
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Candidiasis,23979,409,1.06 [0.93-1.21],0.3969333138993601
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23235,3047,1.09 [1.04-1.14],0.000581502467472
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23442,2471,1.08 [1.02-1.14],0.0058478856444962
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23727,1172,1.12 [1.04-1.21],0.0032554308287594
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23878,80,1.25 [0.93-1.68],0.1344489856499607
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22394,695,1.11 [1.01-1.23],0.0362208661707457
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21634,795,1.14 [1.04-1.25],0.0062647515043891
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21682,215,1.13 [0.94-1.35],0.1847824558395047
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16806,1426,1.13 [1.05-1.21],0.000809746636959
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21489,317,1.20 [1.03-1.39],0.0164785116343507
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23917,1362,1.10 [1.03-1.18],0.0077318283359089
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Mycoses,24032,462,1.08 [0.96-1.22],0.204092282864372
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23380,821,1.12 [1.02-1.23],0.014056531228326
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23985,765,1.11 [1.01-1.22],0.0333569099680096
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22736,181,1.09 [0.90-1.33],0.377518802804052
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24089,38,1.04 [0.68-1.60],0.84356033642818
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23895,675,1.10 [1.00-1.22],0.0621430618412083
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23874,76,1.08 [0.79-1.46],0.6385126993262736
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24004,166,1.27 [1.04-1.56],0.0192665355497673
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23989,151,1.22 [0.99-1.51],0.0652550412751999
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22853,294,1.27 [1.09-1.47],0.0023763528767927
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22786,227,1.04 [0.88-1.25],0.6297469170947477
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22654,99,1.26 [0.97-1.63],0.0853258395461237
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24066,34,1.32 [0.85-2.05],0.2191881237050408
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24020,143,0.91 [0.73-1.14],0.4261946588690211
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral warts,23919,42,0.87 [0.57-1.32],0.5064212754241696
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23948,71,0.93 [0.68-1.28],0.6679574009471669
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm,23843,204,1.13 [0.94-1.36],0.1950234423061353
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23996,58,1.18 [0.84-1.66],0.345971575162448
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23989,59,1.40 [1.00-1.96],0.0495272944535289
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23833,1058,1.00 [0.92-1.09],0.9804073597578704
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of meninges,24065,75,1.26 [0.93-1.71],0.1392630066320019
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24030,60,1.15 [0.82-1.62],0.4072279938633918
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24057,115,1.07 [0.84-1.37],0.5885563519093013
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of ovary,24018,150,1.13 [0.91-1.40],0.264859803021737
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24069,239,0.94 [0.79-1.11],0.4618196227666865
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Caecum,24075,222,0.91 [0.76-1.09],0.3050217101089603
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24009,57,0.82 [0.57-1.17],0.2736250845231965
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Descending colon,24074,134,0.79 [0.62-1.00],0.0526101096467749
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Rectum,24033,246,0.98 [0.83-1.16],0.8252101150319402
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23990,444,0.97 [0.86-1.10],0.6567670685443074
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24074,248,0.92 [0.78-1.09],0.3319421818993965
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Carcinoma in situ of breast,19495,120,0.72 [0.56-0.92],0.0092311487570187
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19568,141,0.89 [0.71-1.11],0.2986522146231443
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19561,30,0.92 [0.56-1.50],0.7343853483542759
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19589,58,1.06 [0.75-1.50],0.737971715772026
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24025,126,0.88 [0.69-1.11],0.2794735591684109
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma, any site",24026,124,0.87 [0.68-1.10],0.242276818580336
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Leiomyoma of uterus,23218,506,1.01 [0.90-1.14],0.8782694125968878
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Lung cancer and mesothelioma,17301,283,0.95 [0.81-1.11],0.5230424363070654
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Lymphoid leukaemia,19566,35,1.07 [0.68-1.67],0.772372370908764
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19687,156,1.08 [0.87-1.33],0.4890271980296382
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19627,96,0.87 [0.66-1.14],0.3077349223909014
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19698,167,0.94 [0.77-1.16],0.5708423035595158
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19591,60,1.21 [0.86-1.70],0.2704757219754675
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19592,61,1.24 [0.88-1.73],0.2158055793823752
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19579,48,1.12 [0.76-1.63],0.5710149442055875
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19662,131,1.05 [0.83-1.32],0.7040347430028169
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19625,94,1.16 [0.88-1.52],0.2981610540395674
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19604,73,1.15 [0.85-1.57],0.3639726920522153
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19567,36,1.36 [0.88-2.09],0.1667084359972122
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19602,71,0.82 [0.60-1.13],0.2293303637891884
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi,23854,206,1.30 [1.09-1.56],0.0044026153128452
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi of trunk,24049,69,1.39 [1.02-1.89],0.0383247910292019
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanoma in situ,19560,77,1.16 [0.86-1.56],0.334967800866201
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19603,72,1.06 [0.78-1.45],0.7003588199187705
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19665,134,1.27 [1.01-1.59],0.040691210441329
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19738,207,0.84 [0.70-1.01],0.0613106338948401
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19614,83,1.51 [1.14-2.01],0.0044038125565867
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Other benign neoplasms of skin,23893,156,1.03 [0.83-1.27],0.7940273081916992
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20346,815,0.99 [0.90-1.09],0.8517674534872035
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20382,851,0.99 [0.90-1.09],0.8553982293614292
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23805,338,1.06 [0.92-1.22],0.4491063841124308
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22346,85,1.12 [0.84-1.50],0.432482782057928
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23538,71,1.38 [1.02-1.88],0.0383985630770643
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23194,2578,1.14 [1.08-1.20],1.009763955341006e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22671,27,1.07 [0.64-1.78],0.7920233627879496
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23741,46,1.96 [1.35-2.85],0.000400689398877
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23573,1312,1.12 [1.04-1.21],0.0018896440036912
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23573,1312,1.12 [1.04-1.21],0.0018896440036912
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22328,67,1.09 [0.79-1.51],0.592829498940395
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23728,1084,1.24 [1.15-1.34],1.1368608004586453e-07
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23796,101,0.93 [0.72-1.22],0.6192063025308534
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23511,44,1.06 [0.71-1.59],0.7702862797039483
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23521,54,1.07 [0.75-1.53],0.7222531905267946
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23902,207,1.21 [1.01-1.45],0.0411216842767002
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23995,53,1.47 [1.03-2.09],0.0331641153294228
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23870,175,0.97 [0.80-1.19],0.80124273651117
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22758,114,1.37 [1.08-1.75],0.0104107555817948
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19435,210,1.03 [0.86-1.24],0.7292203165012456
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22837,60,1.08 [0.77-1.53],0.6455964538824264
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22831,54,1.51 [1.05-2.16],0.0268349752279663
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,19269,44,1.30 [0.87-1.92],0.1981545411399664
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22093,55,1.34 [0.95-1.91],0.0982573728747504
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21811,207,1.04 [0.86-1.24],0.7113419945892434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23703,420,0.95 [0.84-1.08],0.4587450833493632
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23544,261,0.91 [0.77-1.07],0.2606452220428148
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23343,60,1.05 [0.75-1.48],0.7617137516061837
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23746,1708,1.06 [0.99-1.13],0.0937938767279295
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21359,1670,1.07 [1.00-1.14],0.0357314371404278
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",19272,47,1.40 [0.96-2.04],0.0848795205861859
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21424,101,1.05 [0.81-1.37],0.7162812793147277
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19469,244,1.21 [1.02-1.43],0.0261949673966504
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,19267,42,1.18 [0.79-1.77],0.4274580844000556
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21973,2748,1.13 [1.07-1.18],3.7507752917224894e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19406,181,1.05 [0.86-1.28],0.6132547204706933
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19694,469,1.16 [1.02-1.31],0.0188011396338907
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24003,312,1.18 [1.02-1.37],0.0290050064999601
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23836,145,1.26 [1.02-1.56],0.0360552960740487
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19315,90,1.19 [0.90-1.57],0.2190302081085604
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",19274,49,1.43 [0.99-2.08],0.0583620796437306
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23328,2005,1.05 [0.99-1.11],0.1018842908920144
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19399,174,1.10 [0.90-1.35],0.3499135658116553
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19393,168,1.26 [1.03-1.54],0.025710865195365
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19691,466,1.10 [0.97-1.25],0.125427220770042
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19297,72,1.13 [0.83-1.55],0.4309908450256209
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23831,140,1.24 [0.99-1.54],0.0594619959594585
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19760,535,1.02 [0.91-1.14],0.747894877922654
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19709,484,1.13 [1.00-1.27],0.048739624139482
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21667,63,1.27 [0.92-1.77],0.1502587173956085
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23314,4089,1.10 [1.06-1.15],3.4243700996257988e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21389,66,0.92 [0.67-1.28],0.638040895790642
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21401,78,1.08 [0.80-1.45],0.622812222459266
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23922,1789,1.01 [0.95-1.07],0.8434747851972808
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23926,1788,1.01 [0.95-1.07],0.8360939472280777
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21397,74,1.09 [0.80-1.48],0.59806291854294
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23726,1382,1.08 [1.00-1.16],0.0399005166611923
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20523,1298,1.09 [1.01-1.17],0.0231327239714619
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24078,154,1.24 [1.00-1.53],0.0493398775613715
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23323,40,1.26 [0.83-1.90],0.2790662117486231
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22464,120,0.91 [0.72-1.17],0.4756147364204407
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22515,171,1.15 [0.94-1.41],0.1821752117431733
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19443,218,1.26 [1.06-1.51],0.0107100522217704
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22484,120,1.27 [1.00-1.61],0.0491522188772085
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1498,38,0.90 [0.57-1.40],0.6275228388527458
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1593,150,1.15 [0.93-1.43],0.2058757165447919
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22389,25,1.73 [1.03-2.93],0.0399728020404535
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1483,24,1.01 [0.59-1.74],0.9690137599797344
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23677,1313,1.15 [1.07-1.24],0.0002080530985376
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23578,295,0.97 [0.83-1.13],0.6648964265948746
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22020,416,1.10 [0.97-1.25],0.1557331954021063
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19847,622,1.09 [0.98-1.21],0.1022145473197315
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23999,208,0.79 [0.66-0.95],0.0136566523024571
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23194,43,1.09 [0.73-1.62],0.6731546137839775
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Angina pectoris,22746,755,1.19 [1.08-1.31],0.0004363715255247
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23230,79,0.94 [0.70-1.26],0.6699599628502486
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23181,30,1.30 [0.81-2.08],0.2777706193834895
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23289,138,1.12 [0.89-1.40],0.3275843362870135
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15630,1272,1.04 [0.96-1.12],0.3637484510849563
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,AV-block,21127,210,1.00 [0.83-1.20],0.9583105416067113
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24047,268,0.85 [0.72-1.00],0.0505027666189795
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cardiac arrest,14466,108,1.37 [1.07-1.76],0.0141923504545053
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21036,119,0.80 [0.63-1.03],0.0810093491623446
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20988,71,1.05 [0.77-1.44],0.7524394782290118
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24085,27,0.95 [0.57-1.59],0.8588616726444793
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Conduction disorders,21553,636,1.07 [0.96-1.19],0.2004327515135853
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23285,1305,1.13 [1.05-1.21],0.00153870080089
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21679,6398,1.06 [1.02-1.09],0.0015136105852067
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22772,221,0.85 [0.71-1.02],0.0832587781751385
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Endocarditis,20964,47,1.13 [0.77-1.66],0.54383024271748
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24002,729,1.16 [1.05-1.28],0.0035328244917
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertension,22227,5386,1.05 [1.01-1.09],0.0077539173605907
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22236,5395,1.05 [1.01-1.09],0.0071289420397089
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23987,35,0.74 [0.46-1.16],0.1903679022513467
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16995,154,1.05 [0.85-1.30],0.6599192298511309
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16908,67,1.31 [0.95-1.81],0.1029421447987849
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypotension,23970,928,1.00 [0.91-1.09],0.9124388252665804
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23431,86,1.06 [0.80-1.40],0.69824294029572
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23466,1475,1.15 [1.07-1.23],8.377993289678113e-05
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23818,399,1.00 [0.88-1.15],0.9648422852626924
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21187,270,1.11 [0.95-1.31],0.194027220035583
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23899,530,1.12 [1.00-1.26],0.0504933459341395
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22417,426,1.18 [1.04-1.34],0.0100128193949938
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24064,78,1.43 [1.07-1.91],0.0171505990788514
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24081,209,1.13 [0.94-1.35],0.1950142120850244
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Oesophageal varices,22584,33,0.80 [0.50-1.28],0.352140875242247
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other aneurysm,23201,50,0.77 [0.53-1.13],0.1835962641893846
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other arrhythmias,21232,315,1.09 [0.94-1.27],0.2498138802964833
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23212,61,1.47 [1.06-2.05],0.0208329589016071
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23321,170,1.06 [0.87-1.30],0.5714273021687802
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21061,144,0.96 [0.77-1.20],0.7296924115330712
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other disorders of veins,22628,77,0.99 [0.73-1.34],0.957976994173059
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22593,42,1.07 [0.72-1.61],0.7271113171017229
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22998,32,0.78 [0.48-1.27],0.3211859610377162
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22689,138,1.02 [0.81-1.28],0.8566428628516252
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21594,677,1.05 [0.95-1.17],0.3135689347844389
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23079,37,0.81 [0.52-1.26],0.3472876566749331
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23600,449,0.96 [0.84-1.08],0.4791470082334946
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23573,288,0.99 [0.84-1.15],0.8730234894333548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23440,474,1.02 [0.90-1.15],0.7977872260957214
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14609,251,1.12 [0.95-1.33],0.1689184719730074
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23386,246,1.03 [0.87-1.21],0.7725882042588913
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22839,288,0.90 [0.77-1.05],0.1842224138401386
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23676,391,1.06 [0.93-1.21],0.3844038251215385
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24015,504,1.02 [0.91-1.15],0.7063469738854862
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21105,188,1.11 [0.91-1.34],0.3091448486429376
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23566,281,1.00 [0.85-1.17],0.9952520802173688
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23100,134,0.89 [0.70-1.12],0.307891608263965
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23809,464,1.00 [0.88-1.13],0.998296673817491
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23785,505,0.99 [0.88-1.11],0.8066218884777192
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23400,63,0.97 [0.69-1.35],0.853683145984632
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23187,36,1.09 [0.70-1.69],0.7071870163089014
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23602,183,1.08 [0.89-1.32],0.4150125135964634
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23544,175,1.08 [0.88-1.32],0.4492912969390245
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Varicose veins,22939,388,1.00 [0.88-1.15],0.9441424662445594
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23160,82,0.86 [0.64-1.15],0.3102466214820673
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23899,617,1.00 [0.89-1.11],0.9416473807817184
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24050,195,1.06 [0.87-1.28],0.565564575705353
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21411,1615,1.08 [1.01-1.15],0.029430438612629
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Any mental disorder,23559,3763,1.06 [1.02-1.11],0.0065040105366885
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24024,232,1.03 [0.87-1.23],0.7231403148080995
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21522,1726,1.08 [1.01-1.15],0.0212564331535995
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19874,78,0.95 [0.70-1.29],0.7567421491158327
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Smoking dependency,23732,1047,1.10 [1.01-1.19],0.0260722742671386
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21007,1211,1.08 [1.00-1.17],0.0423332379848999
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Vascular dementia,23660,91,0.90 [0.68-1.19],0.4408017368737176
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Alzheimer disease,24087,323,0.89 [0.77-1.03],0.1258521113733363
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16519,52,0.95 [0.65-1.37],0.7772361867993334
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Bell's palsy,22209,72,0.93 [0.68-1.28],0.6613565010575009
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22693,556,1.03 [0.92-1.15],0.6184159409336824
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Cerebral cysts,23737,188,1.09 [0.89-1.32],0.4042039274078542
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24022,239,0.92 [0.77-1.09],0.3160452098496634
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23662,38,0.79 [0.51-1.23],0.3029776049233787
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24076,44,1.41 [0.96-2.09],0.0808360029950669
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23592,43,0.94 [0.62-1.41],0.7521528147465594
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Epilepsy,22812,248,0.98 [0.83-1.16],0.7980391660658204
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23722,1158,1.06 [0.98-1.14],0.1541031150456089
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24043,305,1.08 [0.93-1.25],0.3309738974010878
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23550,2539,0.97 [0.92-1.02],0.2811469163556739
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Generalized epilepsy,23768,42,1.45 [0.98-2.16],0.0640100835704373
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Hemiplegia,23973,190,0.96 [0.79-1.16],0.659328462318699
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Hydrocephalus,23605,56,1.14 [0.81-1.62],0.4561987403834048
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24070,67,1.17 [0.85-1.61],0.3370839628092484
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22249,112,0.87 [0.68-1.12],0.295954308987805
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22192,55,1.27 [0.89-1.80],0.1809774892522697
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Memory loss,23550,93,1.11 [0.84-1.46],0.4593153483925498
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Migraine,23010,446,1.09 [0.97-1.24],0.1593433287222516
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23988,404,1.07 [0.94-1.22],0.3086292506398281
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Motor neuron disease,16607,115,1.03 [0.81-1.32],0.8078527632105668
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23886,126,1.03 [0.81-1.30],0.8320664603792596
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23354,1217,1.02 [0.95-1.10],0.566104080394523
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Neurological diseases,22667,3233,1.02 [0.98-1.07],0.3198390187722601
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23751,127,1.04 [0.82-1.31],0.7700310988336838
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22508,371,1.04 [0.91-1.19],0.5590993384514868
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24035,194,1.10 [0.91-1.33],0.3218687196430412
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19493,580,0.96 [0.86-1.08],0.5263430052727565
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23608,59,1.04 [0.74-1.47],0.8193197399601044
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23660,111,0.96 [0.75-1.24],0.7702874306020523
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23876,138,1.11 [0.89-1.39],0.3711949167029841
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22217,80,0.92 [0.69-1.25],0.6040472166303927
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other headache syndromes,22632,68,1.20 [0.87-1.65],0.2658570317142664
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other neurological diseases,23986,437,1.11 [0.98-1.26],0.1032532127720243
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other sleep disorders,22912,348,1.04 [0.90-1.20],0.5874118250049465
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Parkinson's disease,24064,147,1.01 [0.81-1.26],0.940731636224476
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23622,73,1.35 [1.00-1.84],0.0538053383458583
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Restless leg syndrome,24086,73,0.99 [0.73-1.36],0.9746291888356964
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Sleep apnoea,23933,280,1.02 [0.87-1.20],0.7623949008211865
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23874,33,1.27 [0.81-1.99],0.2997128537282574
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24077,140,0.90 [0.72-1.13],0.3589150274079536
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22199,62,1.03 [0.74-1.45],0.8421370435435762
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24087,326,0.90 [0.77-1.04],0.1485860790780408
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23621,89,0.89 [0.67-1.18],0.4139574844873495
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23568,94,0.83 [0.63-1.09],0.1832393355078872
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23682,429,0.92 [0.80-1.04],0.1844933673839064
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23960,142,1.16 [0.93-1.45],0.1874837191578421
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23114,52,1.33 [0.93-1.91],0.1202567890209823
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23109,47,1.20 [0.82-1.76],0.3536112156563078
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23982,56,1.22 [0.86-1.73],0.2662333163545807
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23836,150,0.91 [0.73-1.14],0.410925006728472
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1490,30,1.11 [0.68-1.82],0.6643548238141481
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1781,56,0.88 [0.61-1.27],0.4928109922058048
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23558,84,0.86 [0.64-1.16],0.3259078076893755
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23938,927,1.09 [1.00-1.19],0.0430975679739578
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23717,655,0.99 [0.89-1.10],0.834081879504506
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23325,263,1.01 [0.86-1.19],0.8765502815990418
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24011,758,0.98 [0.89-1.07],0.6123917053918762
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24075,61,1.21 [0.87-1.70],0.2643507895852049
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23942,689,0.96 [0.87-1.07],0.4610670874217887
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24049,363,0.97 [0.84-1.12],0.6738170751345909
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24002,185,0.97 [0.80-1.17],0.7332457893058331
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23100,38,0.97 [0.62-1.51],0.8874305981573799
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23104,42,1.47 [0.98-2.18],0.0600080182329003
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23123,61,1.06 [0.76-1.49],0.7350389331580007
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24010,624,0.97 [0.87-1.08],0.5884407937520781
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23537,151,0.85 [0.68-1.06],0.1499747468999364
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23311,58,0.94 [0.66-1.34],0.7473425311728545
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23777,91,0.97 [0.73-1.28],0.8079839159559872
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23967,281,0.97 [0.83-1.14],0.7077793735302489
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23437,184,1.00 [0.82-1.21],0.9755403363634108
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23936,119,0.94 [0.73-1.20],0.6087227849400032
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23792,406,0.98 [0.86-1.12],0.7675463713592352
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23613,139,1.01 [0.80-1.26],0.9641530824221372
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22509,2231,1.07 [1.01-1.13],0.0159838980168679
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23934,248,0.95 [0.80-1.12],0.5450501758250933
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24065,143,1.04 [0.84-1.30],0.7116187218691908
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23399,337,1.03 [0.89-1.19],0.6806118730555479
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23745,59,0.83 [0.58-1.18],0.2963703369728188
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24062,48,1.23 [0.84-1.79],0.2911032629075897
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23144,82,0.91 [0.67-1.22],0.512995731263914
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23191,129,0.87 [0.68-1.10],0.2409525843091834
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23106,95,1.23 [0.94-1.61],0.1236517250994848
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23312,59,1.15 [0.82-1.62],0.4230639932157032
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23069,58,0.81 [0.57-1.15],0.2433889480464802
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23492,106,0.97 [0.75-1.26],0.8215665245456166
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23543,157,0.93 [0.75-1.15],0.4884396472494774
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23174,112,1.13 [0.88-1.45],0.3269889583251227
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23094,83,1.33 [1.00-1.76],0.0504590421867252
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23072,61,1.20 [0.86-1.68],0.2940893395478036
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22113,1835,0.99 [0.93-1.05],0.6352245028283826
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23139,77,1.06 [0.79-1.43],0.6990098592957215
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23856,382,0.96 [0.84-1.10],0.5346440173715941
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23514,40,0.93 [0.61-1.41],0.7351825842431494
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23623,149,1.22 [0.99-1.52],0.0643074558857679
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23863,103,0.86 [0.66-1.12],0.2673024993584966
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24045,97,0.95 [0.72-1.24],0.696045407482448
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23979,128,1.06 [0.84-1.33],0.6403194616760106
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23825,65,0.95 [0.69-1.32],0.7720920651874107
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23824,64,1.01 [0.72-1.41],0.9644176050272132
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23993,710,1.06 [0.96-1.17],0.258210169732977
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23767,484,1.11 [0.98-1.25],0.0878150397507878
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23386,103,0.96 [0.74-1.24],0.734928149025095
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23361,78,1.09 [0.81-1.47],0.5591181090577546
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute pharyngitis,23841,73,0.79 [0.58-1.09],0.1504608362082898
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23975,207,0.91 [0.75-1.10],0.3169690733423916
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23826,58,1.10 [0.78-1.56],0.5746371701010025
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,All influenza,22595,114,1.07 [0.84-1.38],0.5702742694154286
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22594,113,1.09 [0.85-1.40],0.4978732962561284
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17134,116,1.21 [0.95-1.54],0.1214718921208819
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Allergic rhinitis,23965,248,1.19 [1.00-1.40],0.0457268855197688
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18698,1841,1.08 [1.02-1.15],0.0127647482184008
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18835,1817,1.08 [1.02-1.15],0.0148395711244298
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23724,114,1.11 [0.86-1.41],0.4261146053046341
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22541,60,1.39 [1.00-1.95],0.0532958259612507
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Bronchiectasis,20804,352,1.29 [1.12-1.48],0.0003382923462154
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20513,61,1.18 [0.84-1.65],0.3322791060501583
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23075,2623,1.09 [1.03-1.14],0.0014810255703064
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22970,58,0.92 [0.65-1.31],0.6527150314570809
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic sinusitis,23039,127,1.15 [0.91-1.46],0.2268159756263003
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23936,908,1.12 [1.03-1.22],0.0116100120346827
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Deviated nasal septum,22978,66,1.02 [0.74-1.41],0.9057125562985148
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22249,4510,1.10 [1.06-1.14],1.6462370538137378e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23210,298,1.10 [0.94-1.28],0.2428525965161118
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Early onset COPD,23315,287,1.11 [0.95-1.30],0.194735918820164
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Emphysema,20686,234,1.39 [1.17-1.64],0.0001565164662562
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22614,202,0.97 [0.80-1.17],0.7239345212004678
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23911,1430,1.08 [1.01-1.16],0.0356163287884676
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Interstitial lung disease,22650,238,0.99 [0.83-1.18],0.9183329866577672
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Later onset COPD,23271,621,1.12 [1.01-1.25],0.0311165350539179
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24080,192,0.96 [0.79-1.17],0.7008676889461052
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Nasal polyp,22973,61,1.10 [0.78-1.53],0.5941947910496965
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23885,813,1.08 [0.98-1.18],0.1109625599672349
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of pleura,23918,1518,1.08 [1.01-1.15],0.0306150739635595
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23602,690,1.17 [1.06-1.29],0.0020625572210952
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other pleural conditions,22435,35,0.89 [0.57-1.40],0.6237992214857027
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24012,301,0.97 [0.83-1.13],0.7130909115643543
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24005,1035,1.13 [1.04-1.23],0.0032912141248614
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pleural effusion,23121,721,1.07 [0.97-1.18],0.1879494741709873
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pleural plaque,22443,43,1.19 [0.79-1.78],0.4045739084361031
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23696,1215,1.07 [1.00-1.16],0.065950656403082
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24053,165,0.94 [0.76-1.15],0.5348506522889478
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pneumothorax,22488,88,1.07 [0.81-1.42],0.6187609090039496
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pollen allergy,24065,208,1.11 [0.93-1.34],0.2452325651882151
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pulmonary oedema,23765,54,0.91 [0.63-1.31],0.6065801291814026
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17062,44,1.66 [1.12-2.45],0.0115616485563268
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23866,794,1.06 [0.97-1.17],0.1896318694222026
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23160,248,1.19 [1.01-1.41],0.0409628482229755
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Viral pneumonia,22667,186,1.12 [0.92-1.36],0.2460124035080805
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23730,147,1.11 [0.89-1.38],0.3649466296246424
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11610,91,1.11 [0.84-1.47],0.4597366179709757
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17228,34,1.14 [0.72-1.79],0.577646496820027
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute appendicitis,23918,123,0.81 [0.63-1.03],0.0812917718789437
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute gastritis,18096,74,1.12 [0.82-1.52],0.4766867526043602
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute pancreatitis,22085,142,1.30 [1.04-1.61],0.0191454790890509
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute peritonitis,23588,75,1.39 [1.03-1.88],0.0292134682371109
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23333,31,0.84 [0.52-1.36],0.4818097502136822
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Barrett oesophagus,18325,303,1.08 [0.93-1.25],0.3391432994631503
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22014,71,1.35 [0.99-1.85],0.0566978104794651
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23714,71,1.34 [0.98-1.84],0.0625960565996927
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholecystitis,22098,155,1.09 [0.88-1.35],0.4122421850754212
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholelithiasis,22984,1041,1.06 [0.98-1.16],0.1310930144830544
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic gastritis,18317,295,1.18 [1.01-1.38],0.0357006424760936
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21980,37,0.80 [0.52-1.24],0.3237668151415957
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24016,64,0.90 [0.65-1.26],0.543528921726768
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Coeliac disease,22747,124,1.06 [0.83-1.34],0.6455335583535601
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Collagenous colitis,22424,95,0.91 [0.69-1.20],0.5081604832980067
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23962,141,1.24 [1.00-1.55],0.0527441090505685
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Constipation,23788,1483,1.05 [0.98-1.13],0.1421871146457294
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn disease,22403,74,1.09 [0.80-1.48],0.5801972147405879
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23766,51,1.10 [0.76-1.59],0.6175201854949639
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22405,76,1.11 [0.82-1.50],0.4991634736664849
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Dental caries,23355,203,1.07 [0.89-1.28],0.5029400624205209
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22656,2136,1.06 [1.00-1.12],0.0616657168887796
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of appendix,23956,161,0.96 [0.78-1.19],0.7365902295152462
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of liver,24000,698,1.07 [0.96-1.18],0.210184482955605
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22075,4053,1.03 [0.99-1.07],0.1589155002247111
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23671,519,1.04 [0.93-1.17],0.4587771512286499
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23977,464,1.18 [1.05-1.34],0.0063493652176888
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23259,107,0.97 [0.75-1.26],0.8393840379353307
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23123,58,0.98 [0.69-1.39],0.8971256583444271
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23831,1208,1.04 [0.96-1.12],0.359184261328776
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of tongue,23128,92,0.94 [0.72-1.24],0.6816602924453445
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23336,1393,1.09 [1.01-1.16],0.0226721177942694
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20001,2807,1.07 [1.01-1.12],0.0119425232216735
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Duodenal ulcer,18139,117,1.19 [0.94-1.53],0.1523255066091696
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24038,97,1.07 [0.81-1.40],0.6354151583586611
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23999,55,1.41 [1.00-1.99],0.051498253104463
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23384,82,0.98 [0.73-1.32],0.9125093942550658
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17297,103,1.39 [1.08-1.79],0.0103374396352008
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Functional dyspepsia,18610,588,1.10 [0.99-1.23],0.0876395088365975
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastric ulcer,18326,304,0.93 [0.80-1.08],0.350400771597288
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20464,2442,1.04 [0.98-1.09],0.1788084974549835
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18441,419,0.99 [0.87-1.13],0.8785285075233007
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18840,7375,1.05 [1.01-1.08],0.0045925057388561
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,GI-bleeding,23590,967,1.03 [0.95-1.13],0.4371806934864523
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23214,62,0.92 [0.65-1.29],0.6185659986931086
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18044,1108,1.14 [1.06-1.24],0.0008277203173424
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23334,32,0.75 [0.47-1.20],0.2343408790793675
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Hernia,23044,2524,1.04 [0.99-1.10],0.1366556412555998
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Impacted teeth,24008,50,1.57 [1.10-2.25],0.0139803773110334
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Impaction of intestines,17255,61,1.26 [0.90-1.76],0.1803424655984548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Inguinal hernia,20666,146,0.93 [0.74-1.15],0.4898597245634468
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,17278,84,0.88 [0.66-1.18],0.385971862203192
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22773,150,1.08 [0.87-1.34],0.492929696767716
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17903,709,1.10 [1.00-1.22],0.0524005055174801
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24077,304,1.20 [1.04-1.40],0.0157127874334271
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23044,715,1.12 [1.02-1.24],0.0217452167164376
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23290,961,1.13 [1.03-1.23],0.0060653175224941
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18155,133,1.34 [1.07-1.68],0.0119720871105154
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophagitis,18528,506,1.06 [0.94-1.19],0.3449622614372999
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24045,143,1.11 [0.89-1.38],0.3623737616549224
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20574,54,1.08 [0.75-1.55],0.675609583323961
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18293,1099,1.03 [0.95-1.11],0.4858394873463002
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22202,259,1.09 [0.93-1.29],0.2858622483117019
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22110,167,1.03 [0.84-1.26],0.7813632884521957
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestine,18584,1390,1.02 [0.95-1.10],0.5004672622512516
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestines,22183,4989,1.04 [1.01-1.08],0.0259681481573424
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23127,205,1.06 [0.88-1.27],0.5414001972995501
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of liver,23884,582,1.08 [0.97-1.21],0.1697006811273521
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18542,520,1.04 [0.92-1.16],0.5433953793908216
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22081,138,1.04 [0.83-1.30],0.7479061659783623
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23919,406,1.15 [1.01-1.31],0.037474903493755
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18965,943,1.04 [0.95-1.13],0.3907859288497957
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23606,983,1.03 [0.95-1.12],0.451641515004012
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23307,155,0.90 [0.73-1.12],0.3455582412157072
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18727,1533,1.07 [1.00-1.14],0.0519408887896112
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19865,1843,1.00 [0.94-1.07],0.92482493460257
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23393,91,1.02 [0.77-1.35],0.8993964583703637
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23176,847,1.10 [1.00-1.20],0.0452290581174104
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17488,294,1.07 [0.91-1.24],0.4159712860628234
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23990,64,1.35 [0.98-1.86],0.0686415795808422
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17631,437,0.99 [0.88-1.13],0.9279749554866766
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22745,122,1.02 [0.80-1.30],0.8722817484612517
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24079,64,0.83 [0.59-1.16],0.2681271176548935
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23153,116,0.96 [0.75-1.23],0.7395024673800736
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Toxic colitis,22385,56,1.14 [0.80-1.63],0.4634251875146806
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18231,209,1.21 [1.01-1.45],0.0417424818330205
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcerative colitis,22479,150,1.29 [1.04-1.59],0.0189583754885196
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22456,127,1.34 [1.07-1.69],0.0121352295862099
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Umbilical hernia,20674,154,0.87 [0.70-1.08],0.1922163806428782
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17362,168,0.98 [0.80-1.20],0.8563678435083687
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ventral hernia,20741,221,1.07 [0.90-1.28],0.4342302240734048
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Volvulus,17268,74,0.84 [0.61-1.15],0.269003630141719
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24012,219,1.22 [1.02-1.46],0.0292780318143761
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23807,75,0.92 [0.68-1.25],0.5831352556978864
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22279,199,1.10 [0.91-1.33],0.3088949618712638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23609,554,1.05 [0.94-1.17],0.4010982151623496
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23185,130,1.07 [0.85-1.35],0.5708737297999831
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22361,281,0.96 [0.82-1.13],0.6617185048436199
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23808,243,1.08 [0.91-1.28],0.3614556369321855
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23987,422,1.02 [0.89-1.16],0.8077533445654123
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23609,44,0.96 [0.64-1.44],0.8530251903369053
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22686,2785,1.03 [0.98-1.09],0.1925168866484739
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23693,412,0.89 [0.78-1.02],0.0848964546917068
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23564,283,0.90 [0.77-1.06],0.2079835037524521
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23800,745,1.03 [0.93-1.13],0.5943025155756843
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24069,69,1.00 [0.73-1.38],0.9955657448576468
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22169,89,0.86 [0.65-1.14],0.2990210601183267
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23321,40,1.16 [0.77-1.75],0.4786804410439398
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23794,229,1.07 [0.90-1.27],0.4714278990779905
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22451,371,1.14 [0.99-1.31],0.0600514476359328
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22127,47,1.09 [0.74-1.60],0.6553309954898638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23996,69,0.83 [0.60-1.14],0.2484746810468163
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23190,135,1.20 [0.96-1.51],0.1083083915654985
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23880,148,0.76 [0.61-0.95],0.0157309267363736
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23609,44,0.96 [0.64-1.43],0.8266559505306704
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22138,58,1.08 [0.77-1.53],0.6464122203374847
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23493,1413,1.06 [0.99-1.14],0.110879826013574
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22482,402,1.14 [1.00-1.30],0.0497246218128408
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22131,51,1.07 [0.74-1.54],0.7291005672408363
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24013,281,0.89 [0.76-1.04],0.150060758775754
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23639,74,0.82 [0.60-1.12],0.2141798661319387
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23947,215,0.87 [0.72-1.04],0.122190558116221
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24039,246,1.16 [0.98-1.37],0.0827579684665537
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22225,145,1.12 [0.90-1.40],0.2956001362030998
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22312,232,0.96 [0.81-1.15],0.6864170109889706
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24027,234,1.17 [0.98-1.39],0.0789927662745721
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22257,177,1.27 [1.05-1.55],0.0162468122095744
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24055,128,1.01 [0.80-1.28],0.9300621626482118
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20549,116,1.04 [0.81-1.33],0.7498952279216585
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21874,5609,1.00 [0.97-1.04],0.8112268019339026
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20653,4388,1.02 [0.98-1.06],0.4441825944059525
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20500,67,1.02 [0.74-1.41],0.9120195716786516
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20670,135,1.14 [0.91-1.43],0.2522415042737418
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20718,183,1.01 [0.83-1.23],0.895892235515107
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23839,102,0.70 [0.54-0.92],0.0112527689591424
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20638,103,1.11 [0.86-1.44],0.416059254613021
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17482,1217,0.97 [0.90-1.05],0.4760059182742376
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23947,201,1.06 [0.88-1.28],0.5364374382820605
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21050,515,1.07 [0.95-1.20],0.2832563035351497
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20235,7147,1.01 [0.98-1.04],0.6296873511065504
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21579,121,1.02 [0.80-1.30],0.8599834825156226
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20554,121,1.14 [0.90-1.45],0.2702790285017318
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21041,608,1.04 [0.93-1.15],0.5175926422717686
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23181,2646,1.04 [0.99-1.10],0.1007840155587422
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20590,157,1.04 [0.84-1.28],0.7359435537428776
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20775,342,1.17 [1.02-1.35],0.0259922774441318
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20590,157,1.16 [0.94-1.43],0.1562461252775277
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23213,94,0.87 [0.66-1.16],0.3420952897378453
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17918,1653,1.03 [0.96-1.10],0.401305164325459
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16448,183,1.18 [0.97-1.43],0.0964765722465738
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24074,180,1.14 [0.93-1.39],0.2032353721547759
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16360,95,1.02 [0.78-1.34],0.8959189840761687
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16776,511,0.85 [0.75-0.95],0.0059881199046006
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20729,296,0.90 [0.77-1.05],0.1835288475394502
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16818,553,0.97 [0.87-1.09],0.6028726622409748
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20594,59,1.17 [0.83-1.65],0.3624683874403133
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21165,630,1.11 [1.00-1.24],0.0462040439950237
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20827,292,1.06 [0.91-1.24],0.4403511832997457
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16777,512,0.98 [0.87-1.10],0.7251803508588259
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20509,76,1.27 [0.94-1.71],0.1205732311504229
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20493,60,1.23 [0.88-1.73],0.2226957778166597
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21503,45,1.20 [0.81-1.78],0.3610807485035202
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23672,2214,1.00 [0.95-1.06],0.96336252320754
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23053,1595,1.01 [0.94-1.08],0.7882885005086187
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23910,522,1.14 [1.02-1.28],0.0250321074171633
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18951,2686,1.02 [0.97-1.08],0.3462715780229694
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16326,61,0.92 [0.65-1.29],0.6179471686536391
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20524,91,1.13 [0.86-1.49],0.3825671229886466
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16307,42,0.89 [0.59-1.35],0.5942234585124236
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16446,181,1.05 [0.86-1.28],0.6268005549917287
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21718,260,0.88 [0.74-1.04],0.1352353125602557
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21960,502,0.99 [0.87-1.11],0.8106317076981034
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24064,98,1.20 [0.92-1.57],0.1680072681827252
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22321,1786,1.07 [1.00-1.14],0.0423795659218035
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20546,113,0.98 [0.76-1.26],0.8825214221317385
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16474,209,0.82 [0.68-0.99],0.0402205216814558
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21245,710,1.04 [0.94-1.14],0.4903390745196037
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18510,2245,0.98 [0.93-1.04],0.4793287017922512
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23232,113,0.86 [0.67-1.12],0.2620259574877922
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24069,73,0.99 [0.73-1.35],0.9438614103472291
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20500,67,1.13 [0.82-1.56],0.4676698602804663
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21732,1299,1.07 [0.99-1.15],0.072123940066227
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20506,73,1.12 [0.82-1.52],0.4769468218210747
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18016,1751,1.06 [1.00-1.13],0.0560938604658278
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21585,127,0.99 [0.78-1.25],0.9112474694926846
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20482,49,0.83 [0.56-1.22],0.3406505593165267
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20711,176,0.91 [0.74-1.11],0.3411921655979048
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20942,509,1.03 [0.91-1.15],0.6756725848536893
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23575,456,1.17 [1.03-1.32],0.0138814181772807
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21100,565,1.10 [0.99-1.23],0.0861629557659688
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23922,505,1.16 [1.03-1.30],0.0150596869895709
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24062,59,1.34 [0.96-1.88],0.0843806673502516
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20632,199,0.98 [0.81-1.18],0.7933497498703852
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18477,806,1.07 [0.97-1.17],0.1814434606262671
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21017,584,1.01 [0.91-1.13],0.8547323247609059
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20540,107,1.10 [0.85-1.42],0.4638971609467039
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16338,73,0.95 [0.69-1.29],0.731361925607376
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18595,2330,1.07 [1.02-1.13],0.0107632770654386
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16999,734,1.05 [0.95-1.16],0.3358128615823126
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23378,259,1.24 [1.05-1.46],0.0102272175921508
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24037,71,1.03 [0.75-1.41],0.8413693346354428
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22067,48,1.19 [0.81-1.73],0.3776070168461889
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16339,74,0.98 [0.72-1.34],0.917548543161757
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20634,99,1.10 [0.84-1.43],0.4953171562936893
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16791,526,1.15 [1.03-1.29],0.0142160799847823
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20714,281,0.85 [0.73-1.00],0.0525111864400339
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20787,252,1.23 [1.04-1.45],0.0155783153038231
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20779,244,1.03 [0.87-1.22],0.7057877688541299
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18574,76,1.36 [1.01-1.83],0.0457942449447254
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24068,65,1.18 [0.85-1.62],0.3283901865286429
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20990,557,0.96 [0.85-1.07],0.4289670345137351
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23269,150,1.12 [0.91-1.39],0.2825894244975547
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22917,2484,1.03 [0.97-1.08],0.3586153487956174
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20574,141,0.77 [0.61-0.96],0.0225770625102183
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21020,485,1.06 [0.94-1.20],0.3205358156264964
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22543,230,0.94 [0.79-1.12],0.4631234448625608
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20754,219,1.07 [0.90-1.28],0.4459513668227458
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22056,1521,1.01 [0.94-1.08],0.8389171761625769
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21571,1036,1.01 [0.93-1.09],0.8622142572493259
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20489,56,0.97 [0.68-1.39],0.8730990667307141
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23334,215,1.02 [0.85-1.22],0.8323068235550737
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20607,174,0.98 [0.80-1.20],0.8365701932142898
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20551,118,0.79 [0.61-1.01],0.0598168835425803
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16309,44,1.51 [1.02-2.23],0.0372679569023078
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23240,1042,1.13 [1.05-1.23],0.0024236231308511
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18017,86,1.14 [0.86-1.51],0.3657138668087336
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23479,103,0.92 [0.70-1.19],0.5153909832089256
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23946,201,1.22 [1.02-1.47],0.0312583029642192
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23767,22,0.61 [0.34-1.09],0.0942188413354713
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23364,1166,1.08 [1.00-1.17],0.046737376251373
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23943,59,0.95 [0.67-1.35],0.7883751183500711
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23912,199,0.99 [0.82-1.19],0.9079160728539606
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Cystitis,21273,219,0.99 [0.83-1.19],0.9349842716159218
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Dialysis,22243,45,1.45 [0.99-2.13],0.0592445449972872
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23666,290,0.98 [0.84-1.14],0.7884594035269973
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Endometriosis,18081,150,1.08 [0.87-1.34],0.5004189239983593
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18273,342,0.88 [0.76-1.02],0.1013133212619239
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18807,876,1.03 [0.95-1.13],0.4605839793966119
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18720,4338,1.05 [1.01-1.09],0.0243387555730405
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23938,54,1.08 [0.76-1.55],0.6703567210544283
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22078,183,1.00 [0.83-1.22],0.9665681967518336
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23600,352,1.02 [0.89-1.18],0.757859572886312
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Irregular menses,23673,108,0.71 [0.55-0.92],0.0105841646514681
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18201,270,1.02 [0.87-1.20],0.8051593758975232
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21122,68,1.22 [0.89-1.68],0.2139059284005251
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,20069,2138,0.99 [0.94-1.05],0.859660414108028
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18051,120,1.14 [0.90-1.45],0.2744037772579147
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24078,57,1.08 [0.75-1.54],0.6822075744927372
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24078,70,0.94 [0.68-1.30],0.7204635209202074
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22990,1936,1.06 [0.99-1.12],0.0767450634030769
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21472,418,1.04 [0.92-1.19],0.5235492311235956
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23477,101,1.00 [0.77-1.30],0.9924916919611928
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24036,323,1.12 [0.96-1.29],0.1462023866699194
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24035,77,0.96 [0.71-1.30],0.8039320652364256
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22710,1656,1.07 [1.00-1.14],0.0510009772176582
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23429,181,1.08 [0.89-1.31],0.4572311980208263
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18067,136,1.22 [0.97-1.53],0.0820407061396302
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18269,338,1.04 [0.90-1.20],0.6080119185310018
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18035,104,1.13 [0.87-1.46],0.3500761250322382
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18114,183,1.12 [0.93-1.37],0.236761560434675
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22123,228,1.04 [0.87-1.24],0.6564858606503501
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23822,109,1.27 [0.99-1.63],0.0597136287854238
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18194,263,1.04 [0.89-1.23],0.6230649947870732
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18023,92,0.87 [0.66-1.15],0.3411446220306949
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18493,562,0.99 [0.89-1.11],0.8947799815397954
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,18070,139,1.26 [1.01-1.57],0.0402868924536117
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18444,513,0.96 [0.85-1.08],0.4742238571958984
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23918,34,1.26 [0.81-1.96],0.3095719017768905
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23932,2037,1.09 [1.03-1.16],0.0032472201186775
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22042,147,1.20 [0.97-1.49],0.0980811755160141
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22277,79,1.07 [0.79-1.43],0.6777661970232225
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23776,31,0.83 [0.51-1.35],0.4561597978373647
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21183,129,1.18 [0.94-1.48],0.1567719796225015
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23976,231,1.15 [0.97-1.37],0.1098311031215428
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18053,122,1.00 [0.79-1.27],0.995812182033642
